Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare, acquired hematologic disorder characterized by the destruction of red blood cells, bone marrow failure, and an increased risk of blood clots. Affecting only a small patient population worldwide, the condition often presents with symptoms such as severe fatigue, anemia, abdominal pain, and hemoglobinuria
For More: https://www.delveinsight.com/report-store/paroxysmal-nocturnal-hemoglobinuria-market
Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size
Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size in the 7MM was valued at ~USD 1300 Million in 2024, and is expected to grow by 2034, DelveInsight
WWW.DELVEINSIGHT.COM
0 0 Reacties 0 Aandelen
Sponsor